RTA cert: No physical share certificates received for demat in Q2 FY27
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts less than Nifty Microcap 250 and 1.8 pts less than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
GENPHARMASEC LIMITED filed a routine SEBI Regulation 74(5) compliance certificate from its Registrar Satellite Corporate Services for the quarter ended 30 September 2026. The RTA confirmed no physical share certificates were received for dematerialization during the quarter. The filing also confirms company securities remain listed on stock exchanges and that any prior dematerialized certificates have been cancelled with the depository recorded as registered owner. This is a standard quarterly compliance requirement.
Routine regulatory compliance filing. No physical share certificates were dematerialized this quarter. No material impact on shareholders or stock price.